Results 51 to 60 of about 28,737 (162)

Mechanism by Which PF-3758309, a Pan Isoform Inhibitor of p21-Activated Kinases, Blocks Reactivation of HIV-1 Latency

open access: yesBiomolecules, 2023
The “block and lock” strategy is one approach that might elicit a sterilizing cure for HIV-1 infection. The “block” refers to a compound’s ability to inhibit latent HIV-1 proviral transcription, while the “lock” refers to its capacity to induce permanent
Benni Vargas   +3 more
doaj   +1 more source

The BAF complex and HIV latency [PDF]

open access: yesTranscription, 2012
The persistence of a reservoir of transcriptionally competent but latent virus in the presence of antiviral regimens presents the main impediment to a curative therapy against HIV. Therefore it is critical to understand the molecular mechanisms, which lead to the establishment and maintenance of HIV latency, and which contribute to the reversal of this
openaire   +3 more sources

Identification of unrecognized host factors promoting HIV-1 latency.

open access: yesPLoS Pathogens, 2020
To counter HIV latency, it is important to develop a better understanding of the full range of host factors promoting latency. Their identification could suggest new strategies to reactivate latent proviruses and subsequently kill the host cells ("shock ...
Zichong Li   +2 more
doaj   +1 more source

Histone deacetylase inhibitors and HIV latency [PDF]

open access: yesCurrent Opinion in HIV and AIDS, 2011
Interest has re-emerged in approaches to eradicate HIV infection. A series of modifications of nucleosomal histones within chromatin are a key mechanism of HIV gene regulation that alters the recruitment of transcription factors to viral DNA. The balance of these histone modifications in the vicinity of the HIV LTR plays an important role in the ...
openaire   +2 more sources

Epigenetic Heterogeneity in HIV-1 Latency Establishment [PDF]

open access: yesScientific Reports, 2015
Despite prolonged antiretroviral therapy, HIV-1 persists as transcriptionally inactive proviruses. The HIV-1 latency remains a principal obstacle in curing AIDS. It is important to understand mechanisms by which HIV-1 latency is established to make the latent reservoir smaller. We present a molecular characterization of distinct populations at an early
Matsuda, Yuka   +5 more
openaire   +2 more sources

Long non-coding RNAs and latent HIV - A search for novel targets for latency reversal.

open access: yesPLoS ONE, 2019
The latent cellular reservoir of HIV is recognized as the major barrier to cure from HIV infection. Long non-coding RNAs (lncRNAs) are more tissue and cell type-specific than protein coding genes, and may represent targets of choice for HIV latency ...
Wim Trypsteen   +10 more
doaj   +1 more source

Latency: the hidden HIV-1 challenge [PDF]

open access: yesRetrovirology, 2006
AbstractEradication of HIV-1 from an infected individual cannot be achieved by current regimens. Viral reservoirs established early during the infection remain unaffected by anti-retroviral therapy for a long time and are able to replenish systemic infection upon interruption of the treatment.
openaire   +3 more sources

Epitranscriptomic m6A modifications during reactivation of HIV-1 latency in CD4+ T cells

open access: yesmBio
Despite effective antiretroviral therapy reducing HIV-1 viral loads to undetectable levels, the presence of latently infected CD4+ T cells poses a major barrier to HIV-1 cure.
Tarun Mishra   +5 more
doaj   +1 more source

HIV latency: experimental systems and molecular models [PDF]

open access: yesFEMS Microbiology Reviews, 2012
Highly active antiretroviral therapy (HAART) has shown great efficacy in increasing the survival of HIV infected individuals. However, HAART does not lead to the full eradication of infection and therefore has to be continued for life. HIV persists in a transcriptionally inactive form in resting T cells in HAART-treated patients and can be reactivated ...
Shweta, Hakre   +3 more
openaire   +2 more sources

Targeting HIV latency: pharmacologic strategies toward eradication [PDF]

open access: yesDrug Discovery Today, 2013
The latent reservoir for HIV-1 in resting CD4(+) T cells remains a major barrier to HIV-1 eradication, even though highly active antiretroviral therapy (HAART) can successfully reduce plasma HIV-1 levels to below the detection limit of clinical assays and reverse disease progression.
Sifei, Xing, Robert F, Siliciano
openaire   +2 more sources

Home - About - Disclaimer - Privacy